לפונקס 100 מ"ג טבליות

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

CLOZAPINE 100 MG

Disponible depuis:

NOVARTIS PHARMA SERVICES AG

Code ATC:

N05AH

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

NOVARTIS PHARMACEUTICALS LTD, UK

Groupe thérapeutique:

DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES

indications thérapeutiques:

For treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for diath.

Date de l'autorisation:

2012-04-01